SteraMist® features efficacy against Influenza A and similar, enveloped viral threat including 2019-nCoV, the current coronavirus outbreak.

EFFICACY AGAINST CORONAVIRUS?

Similar to Influenza A, coronavirus is an enveloped virus. While this would often serve to protect the virus from possible threats, SteraMist® features efficacy against Influenza A and similar, enveloped viral threat including coronavirus.

TOMI has EPA accepted studies on the current label to meet the standard to respond to emerging pathogens in the enveloped and non-enveloped categories, which include, SARS, MERS and 2019-nCoV, the current coronavirus outbreak*.

*For more information, see EPA Registration #90150-2

X
X